Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: vestor who wrote (1093)	4/8/1999 11:53:00 AM
From: muddphudd	Respond to of 1837

So it looks like a hold and wait game for now. OK.

To: vestor who wrote (1093)	4/8/1999 12:37:00 PM
From: Doug Bean	Read Replies (1) \| Respond to of 1837

Vestor i will try to find out when national ad campaign will begin. Margin on the first bunch will be huge as it will be from the original bunch made and then written off when it was turned down the first time. It should have a good margin becasue they were going to be able to undersell Premarin by quite a bit when they were tryiing to compete as a generic. No reason to think that they will have any higher costs now ( other than the amount being paid to Cardinal). I agree that once it starts it should be a steady pull upwards. The medical group here on the thread will let us know what the acceptance will be. If they start moving prescriptions out and reordering.. we will be over the bridge and on our way home :-)) CRDoug